Genitourinary Cancer Clinical Trials

34 clinical trials for Genitourinary Cancer across international registries, including 10 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies — RECRUITING
• Discharge Medication Use Post-Operatively in GU Cancer Patients — RECRUITING
• Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial — RECRUITING · PHASE2
• Ontario-wide Cancer TArgeted Nucleic Acid Evaluation — RECRUITING
• Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK) — RECRUITING
• Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial — RECRUITING · PHASE2
• Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors — RECRUITING
• Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity — RECRUITING · PHASE2
• High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins — RECRUITING · NA
• Genomic Investigation of Unusual Responders — RECRUITING
• Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies — ACTIVE_NOT_RECRUITING · PHASE1
• Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors — ACTIVE_NOT_RECRUITING · PHASE2
• Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study — NOT_YET_RECRUITING · PHASE1
• Integrated Molecular Profiling in Advanced Cancers Trial — ACTIVE_NOT_RECRUITING
• Compare Airway Pressure Release Ventilation (APRV) to Conventional Mechanical Ventila — WITHDRAWN · NA
• Parametric PET of Genitourinary Cancer — COMPLETED · NA
• An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About Cancer — ACTIVE_NOT_RECRUITING · NA
• Pilot Study to Determine Pro-Inflammatory Cytokine Kinetics During Immune Checkpoint Inhibitor Therapy — COMPLETED
• PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer — ACTIVE_NOT_RECRUITING · NA
• Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC) — ACTIVE_NOT_RECRUITING · NA
• Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention — COMPLETED
• Impact of COVID-19 on GU Disease — ACTIVE_NOT_RECRUITING
• Adapting the Tumor Board Model for Mental Illness and Cancer — OTHER · NA
• Next Generation pErsonalized tX(Therapy) With Plasma DNA Trial-2 in Refractory Solid Tumors (The NEXT-2 Trial) — COMPLETED
• Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autologous Cancer — TERMINATED · PHASE1
• Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC) — COMPLETED · PHASE2
• Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers — COMPLETED · PHASE1
• Personal Web Page In Clinical Trial Participant Education — COMPLETED · NA
• RNA Extraction and Amplification From Biopsy Specimens in Subjects With Metastatic Renal Cell Carcinoma (AGS-NTS-017) — TERMINATED · NA
• Feasibility of Activity Monitoring in Patients With Cancer: Physical Activity Monitoring in Cancer Patients (PAMCaP) — COMPLETED
• A Feasibility Trial of Geriatric Assessment and Management for Older Cancer Patients — COMPLETED · NA
• Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous Bypass — COMPLETED
• A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast — TERMINATED · NA

Refine this search